Work

The Novel Proteasome Inhibitor MLN9708 Demonstrates Efficacy in a Genetically-Engineered Mouse Model of DeNovo Plasma Cell Malignancy.

FWCI: 0.219
Cites:
Cited by: 1
Related to: 10